Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (276)	2/23/2007 5:02:19 PM
From: Mike McFarland	Respond to of 360

OT (ands) small position, obviously it takes awhile to get the kid's accounts worth enough to matter. Anadys is cheap enough for me, I don't like to worry about big downside surprises. I paid $3.65 or thereabouts and if I happen to notice it get down around $3 (say, if biotech or the market in general helps drag it down there) I'll probably put our older kid into it too. Doesn't seem like it will do much in the short term however, not expecting a quick flip this time--got lucky last fall, dumb luck and timing. Okay, back on topic: Appointment of Lloyd I. Miller, III to the Board of Directors The Company is pleased to announce it has appointed Lloyd I. Miller, III, a significant investor in the Company, to its board of directors. Mr. Miller is an independent investor and has served on numerous corporate boards, including Vulcan International, American Controlled Industries, and Denny's. He is currently a director of Pharmos Corporation, Stamps.com, and American Banknote, among others. Mr. Miller is a member of the Chicago Board of Trade and the Chicago Stock Exchange, and is a Registered Investment Advisor. Certainly he deserves a seat considering what he's got at stake.